Beijing Leadman Biochemistry Co.,Ltd. (SHE:300289)
China
· Delayed Price · Currency is CNY 5.03
+0.07 (1.41%)
May 20, 2025, 2:45 PM CST
SHE:300289 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Net Income | -73.65 | -75.1 | 15.34 | -56.27 | 22.42 | -50.98 | Upgrade
|
| Depreciation & Amortization | 58.5 | 58.5 | 63.03 | 62.91 | 58.94 | 52.17 | Upgrade
|
| Other Amortization | 8.55 | 8.55 | 7.8 | 5 | 3.05 | 4.48 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | - | - | -0.45 | -1.34 | 0.93 | Upgrade
|
| Asset Writedown & Restructuring Costs | 71.13 | 71.13 | 15.11 | 30.69 | 21.72 | 1.89 | Upgrade
|
| Loss (Gain) From Sale of Investments | -5.93 | -5.93 | -1.77 | -4.13 | -0.07 | -3.42 | Upgrade
|
| Provision & Write-off of Bad Debts | -0.78 | -0.78 | 11.66 | 26.99 | 4.42 | 74.62 | Upgrade
|
| Other Operating Activities | -1.32 | -2.05 | 10.13 | 22.26 | 25.5 | 12.75 | Upgrade
|
| Change in Accounts Receivable | 48.75 | 48.75 | 43.98 | 6.25 | 2.85 | 0.64 | Upgrade
|
| Change in Inventory | -10.23 | -10.23 | 7.78 | 2.88 | -25.24 | -4.99 | Upgrade
|
| Change in Accounts Payable | -26.81 | -26.81 | -34.44 | 16.68 | 11.86 | 46.95 | Upgrade
|
| Operating Cash Flow | 64.59 | 62.41 | 130.8 | 108.93 | 119.06 | 135.56 | Upgrade
|
| Operating Cash Flow Growth | -42.23% | -52.29% | 20.07% | -8.50% | -12.17% | 8.75% | Upgrade
|
| Capital Expenditures | -12.72 | -29.23 | -18.69 | -39.12 | -44.5 | -28.39 | Upgrade
|
| Sale of Property, Plant & Equipment | -0.04 | - | - | 0.59 | 2.14 | 0.05 | Upgrade
|
| Divestitures | - | - | - | - | - | 5.02 | Upgrade
|
| Investment in Securities | -272.45 | -17.45 | -338.27 | -178.83 | - | -0.38 | Upgrade
|
| Other Investing Activities | 7.94 | 7.57 | 3.62 | 4.24 | 0.03 | - | Upgrade
|
| Investing Cash Flow | -277.26 | -39.11 | -353.33 | -213.11 | -42.33 | -23.7 | Upgrade
|
| Short-Term Debt Issued | - | - | - | - | - | 39 | Upgrade
|
| Long-Term Debt Issued | - | - | - | 0.72 | - | - | Upgrade
|
| Total Debt Issued | - | - | - | 0.72 | - | 39 | Upgrade
|
| Short-Term Debt Repaid | - | - | - | - | - | -20.33 | Upgrade
|
| Long-Term Debt Repaid | - | -4.63 | -12.06 | -13.87 | -52.65 | - | Upgrade
|
| Total Debt Repaid | -4.63 | -4.63 | -12.06 | -13.87 | -52.65 | -20.33 | Upgrade
|
| Net Debt Issued (Repaid) | -4.63 | -4.63 | -12.06 | -13.15 | -52.65 | 18.67 | Upgrade
|
| Issuance of Common Stock | - | - | - | - | 550.97 | - | Upgrade
|
| Common Dividends Paid | -5.44 | -5.44 | -0.2 | -10.88 | -0.4 | -7.52 | Upgrade
|
| Other Financing Activities | -7.31 | -6.4 | 1.5 | -0.73 | 1.23 | -56.9 | Upgrade
|
| Financing Cash Flow | -17.38 | -16.47 | -10.76 | -24.76 | 499.15 | -45.74 | Upgrade
|
| Foreign Exchange Rate Adjustments | -0.3 | -0.3 | -0.49 | -0.13 | 0.17 | - | Upgrade
|
| Net Cash Flow | -230.36 | 6.53 | -233.79 | -129.07 | 576.04 | 66.11 | Upgrade
|
| Free Cash Flow | 51.87 | 33.18 | 112.11 | 69.81 | 74.56 | 107.17 | Upgrade
|
| Free Cash Flow Growth | -33.36% | -70.40% | 60.58% | -6.36% | -30.43% | 8.94% | Upgrade
|
| Free Cash Flow Margin | 14.63% | 8.96% | 24.29% | 9.89% | 13.22% | 22.73% | Upgrade
|
| Free Cash Flow Per Share | 0.10 | 0.06 | 0.21 | 0.12 | 0.17 | 0.25 | Upgrade
|
| Cash Income Tax Paid | 37.03 | 43.48 | 61.42 | 60.55 | 60.69 | 52.82 | Upgrade
|
| Levered Free Cash Flow | 60.26 | 23.88 | 78.37 | 51.4 | 94.9 | 132.45 | Upgrade
|
| Unlevered Free Cash Flow | 60.41 | 24.07 | 78.78 | 52.21 | 96.24 | 134.05 | Upgrade
|
| Change in Net Working Capital | -28.15 | -8.63 | -14.13 | -12.21 | -37.11 | -118.81 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.